Michaela Hoffmeyer – Partnering with clients to provide expert guidance on regulatory approval processes

Senior Science Advisor at MRIGlobal – Michaela supports teams in in vitro diagnostic product development for government and commercial clients. She partners with clients to provide expert guidance on regulatory approval processes, including Emergency Use Authorizations for COVID-19 tests.

>> Read More

Gene Olinger, Ph.D. – Working with Industry Partners to Drive COVID-19 Solutions

For more than 20 years he has conducted and supervised in vitro and in vivo experiments in maximum biocontainment (risk level 2-4) at government, industry, and academic laboratories with a focus on high consequence pathogens and biodefense. Dr. Olinger is internationally recognized as a subject matter expert in virology, immunology, biorisk, biosecurity, and biosafety with an emphasis with viral hemorrhagic fevers.

>> Read More

Joe Russell, Ph.D. – Mercury Lab

Senior Scientist in the Global Health Surveillance Division at MRIGlobal, is using hand-held molecular hardware paired with mobile labs to produce even faster result times in the field.

>> Read More

Chris Hollars, Ph.D. – Athena Lab and COVID-19 Testing

Associate Director in the Intelligence, Surveillance and Reconnaissance Division at MRIGlobal who works side-by-side with government clients to provide out of the box solutions for COVID-19 testing.

>> READ MORE

Claire Croutch, Ph.D. – Silverlon and Healing Our Warfighters

MRIGlobal’s toxicologist and senior section manager who recently worked hand-in-hand with Argentum to get Silverlon bandages FDA approval for treating mustard gas burns.

>> READ MORE

Kristine Werking – Diagnostic Testing

Kristine Werking leads MRIGlobal’s newest expansion, the Diagnostics Center of Excellence, and has more than 22 years of experience in laboratory science and project management.

>> READ MORE

John Cobb – Environmental Stresses on Medications

John Cobb manages technical staff in MRIGlobal’s Pharmaceutical Analysis Group, which performs analytical work for both government and commercial clients. John’s work has supported industrial and pharmaceutical products studies and has supported several programs at the National Cancer Institute.